SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-217358
Filing Date
2022-08-10
Accepted
2022-08-10 16:13:07
Documents
53
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d355617d6k.htm   iXBRL 6-K 1473346
7 GRAPHIC g355617g19w01.jpg GRAPHIC 41376
8 GRAPHIC g355617g84c02.jpg GRAPHIC 24730
9 GRAPHIC g355617g94p41.jpg GRAPHIC 123848
  Complete submission text file 0001193125-22-217358.txt   6024236

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA asnd-20220630.xsd EX-101.SCH 46519
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asnd-20220630_cal.xml EX-101.CAL 39480
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asnd-20220630_def.xml EX-101.DEF 193974
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE asnd-20220630_lab.xml EX-101.LAB 317843
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asnd-20220630_pre.xml EX-101.PRE 257995
47 EXTRACTED XBRL INSTANCE DOCUMENT d355617d6k_htm.xml XML 1055678
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 221151963
SIC: 2834 Pharmaceutical Preparations